Scientific Integrity Policy Updates At FDA, CDC Due For Completion In July

HHS-wide update will address agency integrity improvements in the wake of concerns that political considerations inappropriately influenced regulatory decisions related to COVID-19 during the Trump Administration, the General Accountability Office notes in a new report.

HHS Building_1200

More from Regulation

More from Policy & Regulation